K081035 is an FDA 510(k) clearance for the AESCULON C2, AESCULON CHF CLINIC C2, AESCULON HYPERTENSION CLINIC C2 AND AESC.... Classified as Plethysmograph, Impedance (product code DSB), Class II - Special Controls.
Submitted by Osypka Medical, Inc. (La Jolla, US). The FDA issued a Cleared decision on May 30, 2008 after a review of 49 days - a notably fast clearance cycle.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2770 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.